FDA OKs Sublingual Grastek for Timothy Grass Pollen AllergyFDA OKs Sublingual Grastek for Timothy Grass Pollen Allergy

The FDA approved a grass pollen allergen extract for the treatment of Timothy grass pollen-induced allergic rhinitis, with or without conjunctivitis, in individuals aged 5 to 65 years. FDA Approvals
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Alert Source Type: news